AVITA Medical Inc reports results for the quarter ended June 30 - Earnings Summary

• AVITA Medical Inc RCEL.OQ reported a quarterly adjusted loss of 38 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -60 cents. The mean expectation of five analysts for the quarter was for a loss of 25 cents per share. Wall Street expected results to range from -31 cents to -16 cents per share.

• Revenue rose 21.2% to $18.42 million from a year ago; analysts expected $22.61 million.

• AVITA Medical Inc's reported EPS for the quarter was a loss of 38 cents​.

• The company reported a quarterly loss of $9.92 million.

• AVITA Medical Inc shares had risen by 1.7% this quarter and lost 58.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for AVITA Medical Inc is $16.50, about 67.4% above its last closing price of $5.38

This summary was machine generated from LSEG data August 8 at 05:59 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)